[Exceed Announces Strategic Land Purchase Fujian, China Mr. Shuipan Lin, Exceed’s founder, Chairman and CEO, commented, “In an effort to further strengthen Exceed’s position in China’s evolving sportswear market, we initiated a new operational plan in early 2011 to help increase our bargaining power, create greater supply chain stability and ultimately, increase gross profit margin. Expansion of our internal manufacturing] []
[Exceed Announces Strategic Land Purchase Fujian, China Mr. Shuipan Lin, Exceed’s founder, Chairman and CEO, commented, “In an effort to further strengthen Exceed’s position in China’s evolving sportswear market, we initiated a new operational plan in early 2011 to help increase our bargaining power, create greater supply chain stability and ultimately, increase gross profit margin. Expansion of our internal manufacturing] []
[Baidu Announces Fourth Quarter and Fiscal Year 2011 Results BEIJING, China, February 16, 2012 Baidu, Inc. (NASDAQ: BIDU), the leading Chinese language Internet search provider, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2011 1 . Fourth Quarter and Fiscal Year 2011 Highlights Total revenues Total revenues Operating] [BAIDU, INC. By : : Robin Yanhong Li : Chief Executive Officer 6-K 1 d304001d6k.htm FORM 6-K]
[Baidu Announces Fourth Quarter and Fiscal Year 2011 Results BEIJING, China, February 16, 2012 Baidu, Inc. (NASDAQ: BIDU), the leading Chinese language Internet search provider, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2011 1 . Fourth Quarter and Fiscal Year 2011 Highlights Total revenues Total revenues Operating] [BAIDU, INC. By : : Robin Yanhong Li : Chief Executive Officer 6-K 1 d304001d6k.htm FORM 6-K]
[99 TPI Reports Second Quarter Fiscal Year 2012 Financial Results CHENGDU, China, Feb. 14, 2012 -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the second quarter of Fiscal Year 2012. Second quarter fiscal year 2012 ended] [Tianyin Pharmaceutical Inc. (TPI) F2Q12 Earnings Call February 14, 2012 8:30 AM ET Operator Good day ladies and gentlemen thank you for standing by. Welcome to the Tianyin Pharmaceutical Co., Inc., second quarter 2012 annual financial results conference call. During today’s presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be opened for questions.] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT February 14, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
